Clinical Trial Update: Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluates hydroxychloroquine for improving insulin sensitivity in rheumatoid arthritis. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Rheumatoid Arthritis

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Rheumatoid Arthritis, Insulin Resistance | Phase 3 | Status: COMPLETED | Results posted: 2014-09-03